31 results on '"Blaise, D"'
Search Results
2. Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from the SFGM-TC
3. Allogeneic Stem Cell Transplantation from Matched Related Donor in Patients Over the Age of 55 Years After Reduced Intensity Conditioning Associating Fludarabine-Iv Busulfan and Rabbit-Antithymocyte Globulin: A Prospective Multicenter Phase II Clinical Trial with Socio Economic Evaluation
4. Five Versus 2.5 mg/kg of Anti-Thymocyte-Globulin Dose in Reduced-Intensity-Conditioning Reduces Acute and Chronic Graft-Versus-Host Disease for Patients with Myeloid Malignancies Undergoing Allogeneic Stem Cell Transplantation
5. Phase II Prospective Multicenter Study of Treosulfan Based Reduced intensity Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies From 10/10 HLA Identical Unrelated Donor
6. Rituximab in Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Chronic Lymphocytic Leukemia With Fludarabine + Total Body Irradiation Conditioning: Results of a Phase II Prospective Multicenter Study (Itac 02-02)
7. Association Between The Hematopoietic Cell Transplantation-Specific Comorbidity Index (CIn) And Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (Allo-SCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1)
8. The Association Of Fludarabin, Oral Busulfan And Thymoglobulin Prior To Matched Related Allo-SCT Allows For High Long Term Outcome For Both Patients With Myeloid Or Lymphoid Malignancies: Long Term Analysis Of A Homogenous Cohort Of 100 Consecutive Patients
9. Prospective Comparison of Reduced Intensity (Flu-Bu-ATG) vs. Non-Myeloablative (Flu-TBI) Conditioning For Matched Related allo-SCT: A Clinical and Cost-Effectiveness Multicenter ITAC Study (Mini vs. Micro Trial)
10. Tandem Auto-Allo In Acute Myeloid Leukemia (AML) Patients In First Complete Remission (CR)
11. Prognostic Indexes Is Not Predictive Of Treatment Related Mortality In Patients (pts) Older Than 60 Years Treated With Reduced Intensity Conditioning And Allogeneic Stem Cell Transplantation (RIC-ALLO)
12. IV Busulfan-Based Reduced Intensity Regimen (RIC) Before Allogeneic Stem Cell Transplantation Is Well Tolerate And Effective In Patients With Hematological Diseases
13. Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) For Patients Aged ≥60 Years: A Retrospective Analysis Of 629 Patients From The Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
14. Impact of Cytogenetics Risk on Outcome After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) From an HLA Identical Sibling for Patients With Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)
15. Prospective Randomized Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (Flu-Bu-ATG) Conditioning for Hematological Malignancies: A Multicenter ITAC Study
16. Allogeneic Stem Cell Immunotherapy for Advanced Metastatic Breast Cancer: The Way Forward
17. Antithymocyte Globulins (ATG) As Part Of The Myeloablative Conditioning (MAC) Regimen Can Reduce The Risk Of Severe Graft-Vs.-Host Disease (GVHD) After Allogeneic Stem Cell Transplantation (allo-SCT) From Matched-Unrelated Donors (MUD) [A SFGM-TC Study]
18. 168: Unrelated Cord Blood Transplantation in Adults with Lymphoid Malignancies. A Eurocord/EBMT-Lymphoma Working Party Study
19. 356: First line sequential therapy with intensive consolidation chemotherapy and allogeneic hematopoietic stem cell transplantation (ASCT) after reduced intensity conditioning (RIC) for patients with acute myeloblastic leukemia (AML) in first complete remission (CR1)
20. 198: The use of recombinant human erythropoietin (rHuEpo) after reduced intensity conditioning (RIC) allogeneic hematopoietic peripheral blood stem cell transplantation (ASCT) reduces red blood cell (RBC) transfusion requirements
21. European experience of allogeneic hematopoietic stem cell transplantation for metastatic renal carcinoma: On behalf of the french ITAC group and the EBMT Solid Tumour Working Party
22. Early allogeneic stem cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: An intent-to-treat analysis of the long-term experience of the BGMT group
23. Long term infectious complications following reduced intensity conditioning (RIC) allogeneic HLA-identical sibling transplantation (allo-SCT)
24. The role of reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparison
25. Impact of plasmacytoid dendritic cell recovery on outcome after reduced-intensity conditioning allogeneic stem cell transplantation
26. CR1 acute myeloid leukemia and HLA-identical allogeneic transplantation (ASCT) prepared with reduced intensity regimen (RIC): leukemia control requires adequate pre graft chemotherapy and post graft GVHD
27. Allogeneic stem cell transplantation (allo-SCT) from a HLA identical sibling for CR1 AML pts aged above 55 years old after a reduced intensity conditioning: A retrospective study from the Société Française de Greffe de Moelle et de thérapie cellulaire (SFGsm-TC)
28. Predictive factors and impact of full donor T-cell chimerism after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (Allo-SCT)
29. The cytokine storm and acute graft-versus-host disease (aGVHD) after reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT)
30. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
31. High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.